Agios Pharmaceuticals (AGIO) Nukunuku Sɛn
Agios Pharmaceuticals
Prévision IA: AGIO
AI ɖo nɔvɔxɔsisa ɖo xɔsin ɖo gbe ɖagbe, xɔsin ɖo xwe ɖagbe, kpodo xɔsin ɖo xwe ɖagbe kpo. Xɔsin ɖo xɔsin ɖo xɔsin ɖo xɔsin. Xɔsin ɖo xɔsin ɖo xɔsin, ɖo xɔsin ɖo xɔsin.
Prix sur les 6 derniers mois
Premium affiche les objectifs de prix de l'IA pour 1 jour, 1 semaine et 1 mois pour cette action et toutes les autres.
Déverrouiller Premium🔒 Nukunukunukunukunuku
The forecast track record — every past forecast next to the actual close — is part of Premium.
Déverrouiller PremiumGɔn Kɛntɔn E Nɔví
Agios Pharmaceuticals, Inc. develops therapeutic agents for the treatment of cancer. The company’s drug development efforts focus on glycolysis, fatty acid metabolism, and autophagy. Agios Pharmaceuticals operates in the United States.